SFI
HALO icon

Susquehanna Fundamental Investments’s Halozyme HALO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,468
Closed -$233K – 567
2025
Q4 		$233K Sell
3,468
-1,050
-23% -$70.6K 0.01% 499
2025
Q3 		$331K Hold
4,518
– – 0.01% 473
2025
Q2 		$235K Sell
4,518
-31,732
-88% -$1.81M 0.01% 648
2025
Q1 		$2.31M Buy
36,250
+31,732
+702% +$1.84M 0.03% 489
2024
Q4 		$216K Buy
+4,518
New +$232K ﹤0.01% 993
2024
Q2 		$209K Buy
+4,000
New +$175K ﹤0.01% 837

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's HALO Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,468 shares — an estimated $233K sold.

Susquehanna Fundamental Investments first reported a position in HALO in Q2 2024 and held it in 6 quarters. The position peaked at $2.31M in Q1 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 3,468 Halozyme shares in Q1 2026, an estimated $233K.
  • Susquehanna Fundamental Investments first reported a position in Halozyme in Q2 2024 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's Halozyme position peaked at $2.31M in Q1 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.